Attenuating inflammation by inhibition of p38 MAP-kinase does not reduce CV endpoints in LATITUDE TIMI-60 - PACE-CME

Attenuating inflammation by inhibition of p MAPkinase does not reduce CV endpoints in LATITUDE TIMI

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Predicting 30-year CV outcomes in women
Predicting 30-year CV outcomes in women
ESC Congress 2024
Predicting 30-year CV outcomes in women
- Paul Ridker, MD
Exciting times to address residual inflammatory risk
Exciting times to address residual inflammatory risk
EAS 2024
Exciting times to address residual inflammatory risk
- Peter Libby, MD
Pro/con debate: Are we ready to treat inflammation for ASCVD prevention?
Pro/con debate: Are we ready to treat inflammation for ASCVD prevention?
EAS 2024
Pro/con debate: Are we ready to treat inflammation for ASCVD prevention?
- Ulrich Laufs, MD, PhD
- Paul Ridker, MD
The role of inflammation in atherosclerosis
The role of inflammation in atherosclerosis
Inflammation
The role of inflammation in atherosclerosis
- Peter Libby, MD